Tu1200 INTEGRATION OF IN SILICO AND IN VITRO FUNCTIONAL ANALYSIS REVEALS TISSUE FACTOR PATHWAY INHIBITOR 2 (TFPI2) AS A MASTER TRANSCRIPTIONAL REGULATOR AND POTENTIAL TARGET TO IMPEDE INFLIXIMAB RESISTANCE IN ADULT UC PATIENTS